U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

WASHINGTON (AP) — U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

Categories: National & International News